Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2005 Jun 6;92(11):2076-83.
doi: 10.1038/sj.bjc.6602619.

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

Affiliations
Meta-Analysis

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

R Huxley et al. Br J Cancer. .

Abstract

Pancreatic cancer is the eighth major form of cancer-related death worldwide, causing 227 000 deaths annually. Type-II diabetes is widely considered to be associated with pancreatic cancer, but whether this represents a causal or consequential association is unclear. We conducted a meta-analysis to examine this association. A computer-based literature search from 1966 to 2005 yielded 17 case-control and 19 cohort or nested case-control studies with information on 9220 individuals with pancreatic cancer. The age and sex-adjusted odds ratio (OR) for pancreatic cancer associated with type-II diabetes was obtained from each study. The combined summary odds ratio was 1.82 (95% confidence interval (95% CI) 1.66-1.89), with evidence of heterogeneity across the studies (P=0.002 for case-control and P=0.05 for cohort studies) that was explained, in part, by higher risks being reported by smaller studies and studies that reported before 2000. Individuals in whom diabetes had only recently been diagnosed (< 4 years) had a 50% greater risk of the malignancy compared with individuals who had diabetes for > or =5 years (OR 2.1 vs 1.5; P=0.005). These results support a modest causal association between type-II diabetes and pancreatic cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between type-II diabetes and risk of pancreatic cancer in case–control studies. Black square=point estimate (with area proportional to statistical ‘information’, based on inverse of variance of the OR provided by each study) and horizontal line=95% CI for observed effect in each study. *=adjustment for age and sex; **=adjustment for age, sex, smoking or a marker of social class; ***=adjustment for age, sex, smoking and social class; ****=adjustment for age, sex, smoking, social class and dietary variables.
Figure 2
Figure 2
Relationship between type-II diabetes and risk of pancreatic cancer in cohort studies (conventions as in Figure 1).
Figure 3
Figure 3
Sensitivity analyses (conventions as in Figure 1). MR=medical record; OGTT=oral glucose tolerance test; self-report=self-reported diabetes; proxy=diabetes status given by proxy.
Figure 4
Figure 4
Relative risk of pancreatic cancer by duration of diabetes (conventions as in Figure 1).

References

    1. Adami H-O, McLaughlin J, Ekbom A (1994) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2: 307–314 - PubMed
    1. Anderson KE, Johnson TW, Lazovich D, Folsom AR (2002) Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Nat Cancer Inst 94: 1168–1171 - PubMed
    1. Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P, Walker AM (1991) A case–control study of diet and cancer of the pancreas. Am J Epidemiol 134: 167–179 - PubMed
    1. Balkau B, Barrett-Connor E, Eschwege E, Richard J-L, Claude J-R, Ducimetiere P (1993) Diabetes and pancreatic cancer. Diab Metab 19: 458–462 - PubMed
    1. Batty GD, Shipley MJ, Marmot M, Smith GD (2004) Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control 15: 873–881 - PubMed

Publication types